Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Wai Chun Bio-Technology's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$-11.9 Mil.
Wai Chun Bio-Technology's average Total Assets over the quarter that ended in Dec. 2025 was HK$220.5 Mil. Therefore, Wai Chun Bio-Technology's annualized ROA % for the quarter that ended in Dec. 2025 was -5.39%.
The historical rank and industry rank for Wai Chun Bio-Technology's ROA % or its related term are showing as below:
HKSE:00660'
s ROA % Range Over the Past 10 Years
Min: -36.46 Med: -9.09 Max: -1.96
Current: -3.33
During the past 13 years, Wai Chun Bio-Technology's highest ROA % was -1.96%. The lowest was -36.46%. And the median was -9.09%.
HKSE:00660's ROA % is ranked worse than 83.35% of 1616
companies
in the Chemicals industry
Industry Median: 3.045
vs HKSE:00660: -3.33
Wai Chun Bio-Technology (HKSE:00660) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Wai Chun Bio-Technology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wai Chun Bio-Technology ROA % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's ROA % distribution charts can be found below:
* The bar in red indicates where Wai Chun Bio-Technology's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Wai Chun Bio-Technology (HKSE:00660) has a ROA % of -5.39% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Wai Chun Bio-Technology and its competitors. According to the industry distribution chart, Wai Chun Bio-Technology ranks #1347 out of 1616 companies in the Chemicals industry, placing it in the top 83.4%.
Is Wai Chun Bio-Technology's ROA % too high?
Wai Chun Bio-Technology's current ROA % is -5.39%. Based on the distribution chart, Wai Chun Bio-Technology ranks #1347 out of 1616 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's ROA % compare to DOW?
According to the Chemicals industry distribution chart, Wai Chun Bio-Technology ranks #1347 out of 1616 companies for ROA %. This places Wai Chun Bio-Technology in the lower half of its industry. The industry median ROA % is 3.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Chemicals company?
The median ROA % among Chemicals companies is 3.05, based on 1,616 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Wai Chun Bio-Technology and its competitors. For the Chemicals industry, the median ROA % is 3.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wai Chun Bio-Technology's current ROA % is -5.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current ROA % of -5.39%. The current ROA % is -5.39%. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current ROA % is -5.39% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score
Get the complete analysis for HKSE:00660
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00660 has been successfully added to your 
